XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

75,411 resources

By Version

R2: 0
R2B: 0
R3: 3,448
R4: 55,341
R4B: 3,134
R5: 13,264
R6: 224

By Authority

none: 25,640
hl7: 42,405
ihe: 1,382
national: 3,470
who: 2,514

By Realm

none: 22,398
au: 648
be: 387
br: 299
ca: 764
ch: 1,527
cl: 469
cr: 45
cz: 384
de: 2,066
dk: 1,474
ee: 276
eu: 1,253
fi: 87
fr: 1,545
il: 308
in: 163
it: 181
jp: 293
kr: 5
nl: 2,153
no: 26
nz: 79
pl: 83
se: 29
sl: 2
stt: 116
tw: 901
uk: 97
us: 19,481
uv: 17,592
vn: 107
other: 7

Start Prev Rows 53000 - 53200 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1667	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1668	Hereditary Choroidal Dystrophies	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1670	Hereditary Choroidal Dystrophies	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1671	Hereditary Retinal Dystrophies	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1673	Hereditary Retinal Dystrophies	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1677	Nystagmus and Other Irregular Eye Movements	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1679	Nystagmus and Other Irregular Eye Movements	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1680	Optic Atrophy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1682	Optic Atrophy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1683	Optic Neuritis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1685	Optic Neuritis	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1686	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1688	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1689	Other Background Retinopathy and Retinal Vascular Changes	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1691	Other Background Retinopathy and Retinal Vascular Changes	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1695	Other Disorders of Optic Nerve	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1697	Other Disorders of Optic Nerve	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1701	Other Endophthalmitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1703	Other Endophthalmitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1707	Prior Penetrating Keratoplasty	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1709	Prior Penetrating Keratoplasty	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1713	Purulent Endophthalmitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1715	Purulent Endophthalmitis	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1716	Retinal Detachment with Retinal Defect	active	2022-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1718	Retinal Detachment with Retinal Defect	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1719	Retinal Vascular Occlusion	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1721	Retinal Vascular Occlusion	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1722	Other Proliferative Retinopathy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1724	Other Proliferative Retinopathy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1728	Separation of Retinal Layers	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1730	Separation of Retinal Layers	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1731	Visual Acuity 20/40 or Better	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.175	Hypotension	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1752	Speech and Hearing Evaluation	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.176	Arrhythmia	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1766	Morgagnian Cataract	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1767	Morgagnian Cataract	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1769	Macular Scar of Posterior Polar	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.177	Atrioventricular Block	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1770	Macular Scar of Posterior Polar	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1771	Ophthalmological Services	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1772	Annual Wellness Visit	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1773	Speech and Hearing Evaluation	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1774	Occupational Therapy Evaluation	active	2021-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1775	Behavioral Neuropsych Assessment	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1776	Psych Visit Diagnostic Evaluation	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1777	Psych Visit Psychotherapy	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1778	Psychoanalysis	active	2019-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1779	Group Psychotherapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.178	Cardiac Pacer in Situ	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1780	Psych Visit for Family Psychotherapy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1781	Best Corrected Visual Acuity Exam Using Snellen Chart	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.180	Hypotension	active	2023-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.181	Arrhythmia	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.183	Cardiac Pacer in Situ	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.185	Hypotension	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.186	Arrhythmia	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.187	Atrioventricular Block	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1912	Major Depressive Disorder Active	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1918	Major Depressive Disorder Active	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1923	Psych Visit Diagnostic Evaluation	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.1924	Cardiac Pacer in Situ	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.408	Bradycardia	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.410	Bradycardia	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.411	Bradycardia	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.422	Tobacco User	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.423	Tobacco Use Cessation Pharmacotherapy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.424	Tobacco Use Cessation Counseling	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.425	Tobacco Use Cessation Counseling	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.450	Pain Warranting Further Investigation for Prostate Cancer	active	2023-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.469	Bilateral Oophorectomy	active	2017-09	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.470	Bilateral Oophorectomy	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.483	Chemotherapy	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.484	Chemotherapy	active	2021-08	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.511	Tobacco Non User	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.532	Pregnancy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.56	Coronary Artery Disease No MI	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.57	Coronary Artery Disease No MI	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.58	Initial Myocardial Infarction	active	2024-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.589	End Stage Renal Disease	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.59	Asthma	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.590	End Stage Renal Disease	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.60	Asthma	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.61	Asthma	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.73	Primary Open Angle Glaucoma	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.74	Primary Open Angle Glaucoma	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.76	Diabetic Retinopathy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.80	Diabetic Retinopathy	active	2025-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.859	Left Ventricular Systolic Dysfunction	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.860	Moderate or Severe	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.861	Moderate or Severe LVSD	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.91	Prostate Cancer	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.2.92	Prostate Cancer	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1002	Chronic Kidney Disease, Stage 5	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1005	Dementia and Mental Degenerations	active	2020-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1006	Standardized Tools Score for Assessment of Cognition	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1007	Medical Reason	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1008	Patient Reason	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1010	Cancer	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1011	Occupational Therapy Evaluation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1012	Patient Provider Interaction	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1018	Psych Visit for Family Psychotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1023	Behavioral or Neuropsych Assessment	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1026	Radiation Treatment Management	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1027	Chemotherapy Administration	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1028	Standardized Pain Assessment Tool	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1090	Moderate or Severe LVSD	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1091	Left Ventricular Systolic Dysfunction	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1092	Moderate or Severe	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1134	Ejection Fraction	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1139	ACE Inhibitor or ARB or ARNI	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1140	Patient Reason for ACE Inhibitor or ARB Decline	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1141	Psychoanalysis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1151	Renal Failure Due to ACE Inhibitor	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1170	Tobacco User	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1174	Beta Blocker Therapy	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1176	Heart Rate	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1177	Allergy to Beta Blocker Therapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1178	Intolerance to Beta Blocker Therapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1184	Beta Blocker Therapy for LVSD	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1187	Group Psychotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1189	Tobacco Non User	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1190	Tobacco Use Cessation Pharmacotherapy	active	2017-05	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1193	Cardiac Pacer	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1211	Allergy to ACE Inhibitor or ARB	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1212	Intolerance to ACE Inhibitor or ARB	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1240	Annual Wellness Visit	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1241	Acute and Subacute Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1251	Macular Exam	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1259	Limited Life Expectancy	active	2025-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1278	Tobacco Use Screening	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1283	Level of Severity of Retinopathy Findings	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1285	Ophthalmological Services	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1320	Macular Edema Findings Present	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1332	Cognitive Assessment	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1333	Cup to Disc Ratio	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1334	Optic Disc Exam for Structural Abnormalities	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1409	Burn Confined to Eye and Adnexa	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1410	Cataract Secondary to Ocular Disorders	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1411	Cataract Surgery	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1412	Cataract Congenital	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1413	Cataract Mature or Hypermature	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1414	Cataract Posterior Polar	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1415	Certain Types of Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1416	Chronic Iridocyclitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1417	Cloudy Cornea	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1418	Corneal Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1419	Disorders of Cornea Including Corneal Opacity	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1423	Glaucoma	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1424	Hereditary Corneal Dystrophies	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1426	Hypotony of Eye	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1427	Injury to Optic Nerve and Pathways	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1428	Central Corneal Ulcer	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1430	Open Wound of Eyeball	active	2021-04	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1432	Pathologic Myopia	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1433	Posterior Lenticonus	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1438	Retrolental Fibroplasias	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1443	Traumatic Cataract	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1444	Uveitis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1445	Vascular Disorders of Iris and Ciliary Body	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1446	Visual Field Defects	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1448	Amblyopia	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1450	Choroidal Degenerations	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1451	Choroidal Detachment	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1452	Choroidal Hemorrhage and Rupture	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1453	Degeneration of Macula and Posterior Pole	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1454	Degenerative Disorders of Globe	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1455	Diabetic Macular Edema	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1457	Disorders of Optic Chiasm	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1458	Disorders of Visual Cortex	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1459	Disseminated Chorioretinitis and Disseminated Retinochoroiditis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1460	Focal Chorioretinitis and Focal Retinochoroiditis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1461	Glaucoma Associated with Congenital Anomalies and Dystrophies and Systemic Syndromes	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1462	Hereditary Choroidal Dystrophies	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1463	Hereditary Retinal Dystrophies	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1465	Nystagmus and Other Irregular Eye Movements	active	2021-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1466	Optic Atrophy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1467	Optic Neuritis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1468	Other and Unspecified Forms of Chorioretinitis and Retinochoroiditis	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1469	Other Background Retinopathy and Retinal Vascular Changes	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1471	Other Disorders of Optic Nerve	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1473	Other Endophthalmitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1475	Prior Penetrating Keratoplasty	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1477	Purulent Endophthalmitis	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1478	Retinal Detachment with Retinal Defect	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1479	Retinal Vascular Occlusion	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1480	Other Proliferative Retinopathy	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1482	Separation of Retinal Layers	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1483	Visual Acuity 20/40 or Better	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1491	Major Depressive Disorder Active	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1492	Psych Visit Diagnostic Evaluation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1496	Psych Visit Psychotherapy	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1530	Speech and Hearing Evaluation	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1558	Morgagnian Cataract	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1559	Macular Scar of Posterior Polar	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1560	Best Corrected Visual Acuity Exam Using Snellen Chart	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1561	Medications for Above Normal BMI	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1562	Medications for Below Normal BMI	active	2021-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1563	Underweight	active	2022-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113883.3.526.3.1566	Adult Depression Medications	active	2021-02	us	hl7